In the past 30 years, improvement in preoperative diagnostics, surgical techniques, intensive therapy, and adjuvant chemoradiation enabled expert centers to achieve excellent results in operative mortality and 5-year survival, introducing the term “cure” among goals of esophageal cancer treatment.
1 x 1 Stein, HJ, von Rahden, BH, and Siewert, JR. Survival after oesophagectomy for cancer of the oesophagus. Langenbecks Arch Surg. 2005; 390: 280–285 Crossref | PubMed | Scopus (30) | Google Scholar See all References Nevertheless, little is known if these patients are really cured of their malignant disease, or the reported, admittedly improved survival rates are just consequences of an institutional selection bias, changing epidemiology of esophageal carcinoma, or in cases of early cancer, products of lead time bias and a short follow-up.
2 x 2 Welch, HG, Schwartz, LM, and Woloshin, S. Are increasing 5-year survival rates evidence of success against cancer?. JAMA. 2000; 283: 2975–2978 Crossref | PubMed | Scopus (290) | Google Scholar See all References
x 3 MacDonald, AJ, McEwan, H, McCabe, M et al. Age at death of patients with colorectal cancer and the effect of lead-time bias on survival in elective vs emergency surgery. Colorectal Dis. 2011; 13: 519–525 Crossref | PubMed | Scopus (12) | Google Scholar See all References –
4 x 4 Croswell, JM, Ransohoff, DF, and Kramer, BS. Principles of cancer screening: lessons from history and study design issues. Semin Oncol. 2010; 37: 202–215 Abstract | Full Text | Full Text PDF | PubMed | Scopus (102) | Google Scholar See all References To minimize these biases and assess national temporal trends in long-term survival and possible cure rates in patients with carcinoma of the esophagus and the gastric cardia, we analyzed Surveillance, Epidemiology, and End Results (SEER) cancer registry data, comparing cancer-related survival in each stage through the last 3 decades in the United States.